Significance of Artificial Intelligence in Medicines

Authors

  • Dr. Samir Sahu Department of Medical, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar Author
  • Dr. Udayabhanu Rout Department of Medical, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar Author
  • Dr Mihir Narayan Mohanty Department of Medical, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar Author

DOI:

https://doi.org/10.61841/atz9ch61

Keywords:

Artificial Intelligence, Applications, Medicines, Nano-robots, Physical, Virtual, Medical Diagnosis

Abstract

“Artificial Intelligence” (AI) is a common term implying that a computer is used to design intelligent behaviour with very less percentage of human involvement. Artificial Intelligence is generally considered to have begun with the robots inventions. The term applies to a wide range of biomedical products like medical diagnosis, robots, human biology-up and scientific data including the “omics” of today. AI has two main branches of science, which is the subject of this review: physical and virtual. The virtual field encompasses digital methods, including electronic health records, from deep learning information management to control systems in health management and constructive support for physicians in their treatment decision. The best representation for the physical branch is robots used to assist the attending surgeon or elderly patient. Targeted “Nano-robots”, a unique new drug delivery system, are also embodied in that branch. These applications ' societal and ethical complexities require further reflection, proof of their medical utility, economic value, and the development of interdisciplinary strategies for their wider use.

Downloads

Download data is not yet available.

References

[1] D. R. Yates, C. Vaessen, and M. Roupret, “From Leonardo to da Vinci: The history of robot-assisted surgery in urology,” BJU International. 2011.

[2] J. Tiemensma, C. D. Andela, A. M. Pereira, J. A. Romijn, N. R. Biermasz, and A. A. Kaptein, “Patients with adrenal insufficiency hate their medication: Concerns and stronger beliefs about the necessity of hydrocortisone intake are associated with more negative illness perceptions,” J. Clin. Endocrinol. Metab., 2014.

[3] C. T. O’Neill, N. S. Phipps, L. Cappello, S. Paganoni, and C. J. Walsh, “A soft wearable robot for the shoulder: Design, characterization, and preliminary testing,” in IEEE International Conference on Rehabilitation Robotics, 2017.

[4] C. Breazeal, “Designing Sociable Robots,” in Designing Sociable Robots, 2018.

[5] A. Laborde et al., “Children’s health in Latin America: The infuence of environmental exposures,” Environmental Health Perspectives. 2015.

[6] T. A. Munandar, Suherman, and Sumiati, “The Use of Certainty Factor with Multiple Rules for Diagnosing Internal Disease,” ijaiem, 2012.

[7] P. Hamet and J. Tremblay, “Artificial intelligence in medicine,” Metabolism., 2017.

[8] R. Kapoor, S. P. Walters, and L. A. Al-Aswad, “The current state of artificial intelligence in ophthalmology,” Survey of Ophthalmology. 2019.

[9] V. Y. Londhe and B. Bhasin, “Artificial intelligence and its potential in oncology,” Drug Discovery Today. 2019.

[10] P. D. Morris et al., “Computational fluid dynamics modelling in cardiovascular medicine,” Heart, 2016.

[11] V. B. Kolachalama and P. S. Garg, “Machine learning and medical education,” npj Digit. Med., 2018.

[12] K. N. DuBois, “DEEP MEDICINE: How Artificial Intelligence Can Make Healthcare Human Again,” Perspect. Sci. Christ. Faith, 2019.

[13] I. Boon, T. Au Yong, and C. Boon, “Assessing the Role of Artificial Intelligence (AI) in Clinical Oncology: Utility of Machine Learning in Radiotherapy Target Volume Delineation,” Medicines, 2018.

[14] D. Madhu, C. J. N. Jain, E. Sebastain, S. Shaji, and A. Ajayakumar, “A novel approach for medical assistance using trained chatbot,” in Proceedings of the International Conference on Inventive Communication and Computational Technologies, ICICCT 2017, 2017.

[15] A. Heifets and I. Jurisica, “Construction of new medicines via game proof search,” in Proceedings of the National Conference on Artificial Intelligence, 2012.

[16] P. V. Henstock, “Artificial Intelligence for Pharma: Time for Internal Investment,” Trends in Pharmacological Sciences. 2019.

Downloads

Published

30.11.2019

Issue

Vol. 23 No. 6 (2019): 23 (6) 2019

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Sahu, S., Rout, U., & Mohanty , M. N. (2019). Significance of Artificial Intelligence in Medicines. International Journal of Psychosocial Rehabilitation, 23(6), 657-663. https://doi.org/10.61841/atz9ch61